RUSSO, Diego
 Distribuzione geografica
Continente #
NA - Nord America 5.222
AS - Asia 4.144
EU - Europa 1.545
SA - Sud America 1.138
AF - Africa 77
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 12.142
Nazione #
US - Stati Uniti d'America 4.987
SG - Singapore 1.840
CN - Cina 1.036
BR - Brasile 895
IT - Italia 653
VN - Vietnam 528
IN - India 457
SE - Svezia 291
GB - Regno Unito 183
DE - Germania 169
CA - Canada 161
AR - Argentina 102
FI - Finlandia 58
EC - Ecuador 55
TR - Turchia 54
BD - Bangladesh 49
MX - Messico 48
ID - Indonesia 38
RU - Federazione Russa 26
UA - Ucraina 25
ZA - Sudafrica 24
ES - Italia 23
CO - Colombia 20
HK - Hong Kong 19
IQ - Iraq 18
IR - Iran 18
NL - Olanda 18
PY - Paraguay 18
PL - Polonia 16
CL - Cile 15
JP - Giappone 15
RO - Romania 15
EE - Estonia 13
FR - Francia 13
AE - Emirati Arabi Uniti 11
EG - Egitto 11
MA - Marocco 11
PE - Perù 11
VE - Venezuela 11
PK - Pakistan 9
DO - Repubblica Dominicana 8
IE - Irlanda 8
SA - Arabia Saudita 8
TN - Tunisia 8
UY - Uruguay 8
UZ - Uzbekistan 8
DZ - Algeria 7
GR - Grecia 6
JM - Giamaica 6
KR - Corea 6
AT - Austria 5
AU - Australia 5
CZ - Repubblica Ceca 5
IL - Israele 5
KE - Kenya 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BE - Belgio 4
ET - Etiopia 4
SV - El Salvador 4
AZ - Azerbaigian 3
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
EU - Europa 3
HR - Croazia 3
JO - Giordania 3
KZ - Kazakistan 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CR - Costa Rica 2
LB - Libano 2
NZ - Nuova Zelanda 2
PA - Panama 2
SC - Seychelles 2
SN - Senegal 2
TW - Taiwan 2
AL - Albania 1
BY - Bielorussia 1
DK - Danimarca 1
GN - Guinea 1
GT - Guatemala 1
HN - Honduras 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MG - Madagascar 1
MY - Malesia 1
NA - Namibia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
PW - Palau 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.142
Città #
Chandler 778
Dallas 662
Singapore 503
Santa Clara 402
Hefei 373
Bengaluru 372
Princeton 360
Lawrence 359
Milan 351
Ho Chi Minh City 207
Wilmington 197
Ashburn 193
London 144
Chicago 143
Munich 120
Ottawa 119
Des Moines 118
Beijing 105
Hanoi 105
São Paulo 74
Boardman 66
Shanghai 57
Los Angeles 47
Turku 46
Catanzaro 42
Council Bluffs 42
Norwalk 37
Haiphong 33
Rio de Janeiro 33
Guangzhou 29
Da Nang 25
New York 25
Shenzhen 25
Brooklyn 23
Redwood City 22
Pune 21
Hong Kong 19
Curitiba 18
Guayaquil 18
Quito 18
Rome 18
Thái Bình 18
Hanover 17
Istanbul 17
San Francisco 17
Chennai 15
Jiaxing 15
Belo Horizonte 14
Mexico City 14
Montreal 14
Washington 14
Ankara 13
Brasília 13
Ninh Bình 13
Porto Alegre 13
Seattle 13
Atlanta 12
Campinas 12
Johannesburg 12
Redmond 12
Delhi 11
Manaus 11
Salvador 11
Tokyo 11
Biên Hòa 10
Boston 10
Helsinki 10
Horia 10
Phoenix 10
Stockholm 10
Warsaw 10
Ann Arbor 9
Hortolândia 9
Quanzhou 9
Toronto 9
Xi'an 9
Abu Dhabi 8
Baghdad 8
Bauru 8
Buffalo 8
Dhaka 8
Fortaleza 8
Guarulhos 8
Hải Dương 8
Jakarta 8
Montevideo 8
Nottingham 8
Rui'an 8
Santo André 8
The Dalles 8
Voghera 8
Wuhan 8
Wuxi 8
Buenos Aires 7
Catania 7
Columbus 7
Dublin 7
Goiânia 7
Lima 7
Recife 7
Totale 6.961
Nome #
Biological Activity of Oleuropein and Its Derivatives 166
Anti-hTERT siRNA-loaded nanoparticles block the growth of anaplastic thyroid cancer xenograft 76
A case of metastatic medullary thyroid carcinoma: early identification before surgery of a ret proto-oncogene somatic mutation in fine needle aspirate specimen 75
Impact of legumes and plant proteins consumption on cognitive performances in the elderly 72
Antiproliferative Effects of Cynaropicrin on Anaplastic Thyroid Cancer Cells 71
Precision oncology for RET-related tumors 70
A large family with hereditary MTC: role of RET genetic analysis in differential diagnosis between MEN 2A and FMTC 70
Antioxidant and antigrowth action of peracetylated oleuropein in thyroid cancer cells 70
Mediterranean Diet Nutrients to Turn the Tide against Insulin Resistance and Related Diseases 68
Hashimoto's thyroiditis and vestibular dysfunction 67
Absence od Sodium/Iodide symporter gene mutations in differentiated human thyroid carcinomas 66
A case of anaplastic Diffuse Large B-Cell Thyroid Lymphoma: unique immunophenotype and unusual clinical presentation 66
Antiproliferative effects afforded by pyrazolopyrimidine derivates on human neuroblastoma cells 66
Antiproliferative and antioxidant effects of oleuropein and its semisynthetic peracetylated derivatives on breast cancer cells 66
A novel mutation in the thyrotropin receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistence to TSH 65
Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer 65
Liposomes as multicompartmental carriers for multidrug delivery in anticancer chemotherapy 64
A thyroid follicular cancer presenting as a hot nodule and hyperfunctioning because of an activating mutation of the TSH receptor 64
Association between low C-peptide and fragility fractures in postmenopausal women without diabetes 64
A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH 64
IL-20 Subfamily Biological Effects: Mechanistic Insights and Therapeutic Perspectives in Cancer 62
A novel mutation in the Thyrotropin receptor gene causing loss of TSH binding but constitutive activation in a family with resistance to TSH 62
A Phe 486 TSH receptor mutation in a autonomously functioning follicular carcinoma that was causing hyperthyroidism 61
TSH-CONJUGATED NANOCARRIER FOR THE TREATMENT OF THYROID CANCER 61
Anti-hTERT siRNA nanoparticles block the growth of anaplastic thyroid cancer cells in vitro and in vivo. 60
A hyperfunctioning Hurtle cell thyroid carcinoma with a mutation in the thyrotropin receptor 60
A Val 677 activating mutation of the Thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis 60
Lipoamino Acid Prodrugs of Paclitaxel: Synthesis and Cytotoxicity Evaluation on Human Anaplastic Thyroid Carcinoma Cells 59
Activating mutations of the TSH Receptor in differentiated thyroid carcinomas 58
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: Functional characterization 58
Adenyl cyclase activity and Gs and Gi alpha ADP-ribosylation in thyroid hyperfunctioning adenomas presenting TSH receptor or Gsp mutations 58
Antiproliferative activity of PDE5 inhibitors vehicled by nanovescicles in thyroid cancer cells. 58
Antiproliferative activity of PDE5 inhibitors vehicle by nanovesicles in thyroid cancer cells. 57
A Val677 activating mutation of the thyrotropin receptor in a Hurtle cell thyroid carcinoma associated with thyrotossicosis 56
Evaluation of biological effects of TERT inhibition in human thyroid cancer cells 56
Antiproliferative activity of PDE5 inhibitors vehicled by nanovesicles in thyroid cancer cells 55
Absence of iodide symporter gene mutations in human thyroid tumors 55
Epigenetic-related gene expression profile in Medullary Thyroid Cancer revealed the overexpression of the Histone methyltransferases EZH2 and SMYD3 in aggressive tumours. 55
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with pheochromocytoma and medullary thyroid carcinoma: Functional characterization 55
Antiproliferative Effects of Two Pyrazolo-Pyrimidine Derivates on Human Anaplastic Thyroid Cancer Cells 55
Antioxidant and antiproliferative effects of olive-leaf extract oleuropein and its peracetylated derivate on human thyroid cancer cells 53
A case of metastatic medullary thyroid carcinoma: Early identification before surgery of an RET proto-oncogene somatic mutation in fine-needle aspirate specimens 53
Expression and cellular localization of Ref-1 in human thyroid carcinoma cell lines 52
Antiproliferative effects of olive-leaf extract oleuropein and derivatives in human breast cancer cells 51
Carcinomi differenziati della tiroide: ruolo oncogenico del recettore del TSH 50
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma. 50
Effects of Oleacein on High-Fat Diet-Dependent Steatosis, Weight Gain, and Insulin Resistance in Mice 50
Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells 49
Functional analysis of the cytoplasmic domains of the human TSH receptor by site-directed mutagenesis. 49
A novel germline VHL gene mutation in two different patients with pheochromocytoma. 49
NANOVETTORE CONIUGATO CON TSH PER IL TRATTAMENTO DEL CANCRO DELLA TIROIDE 49
Analisi della proteina APE/Ref-1 nei noduli tiroidei iperfunzionanti: aumento dell’espressione nelle frazioni nucleari 49
A new structural model for the Thyrotropin receptor as determined by covalent crosslinking of Thyrotropin to the recombinant receptor in intact cells: evidence for a single polypeptide chain. 48
A Val677 activating mutation of the thyrotropin receptor in a Hürtle cell thyroid carcinoma associated with thyrotoxicosis 48
Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer. 48
Vestibular disorders in euthyroid patients with Hashimoto’s thyroiditis: role of thyroid autoimmunity. 48
Aqueous–core PEG-coated PLA nanocapsules for an efficient entrapment of water soluble anticancer drugs and a smart therapeutic response 47
Genetic analysis in fine needle aspiration of the thyroid: a new tool for clinic 47
APE/Ref-1 is increased in nuclear fractions of human thyroid hyperfunctioning nodules 47
Maggisano V., Capriglione F., Mio C., Bulotta S., Damante G., Russo D., Celano M 46
Expression and localization of the sodium/iodide symporter (NIS) in testicular cells 46
Ape1/Ref-1 is increased in nuclear fractions of human thyroid hot nodules 46
Functional interaction among thyroid specific transcription factors: PAX8 regulates the activity of Hex promoter 46
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells 46
Absence of Sodium-Iodide Symporter gene mutations in differentiated human thyroid carcinomas 45
Alterazioni del trasportatore dello iodio in patologia tiroidea 45
Expression of adenylyl cyclase types III and VI in human hyperfunctioning thyroid nodules 45
A call to action: Now is the time to screen elderly and treat osteosarcopenia, a position paper of the italian college of academic nutritionists med/49 (ican-49) 45
Eleven amino acids (Lys-201 to Lys-211) and 9 amino acids (Gly-222 to Leu-230) in the human thyrotropin receptor are involved in ligand binding. 44
Expression of leptin receptor and effects of leptin on papillary thyroid carcinoma cells 44
Different molecular mechanisms are involved in the multihormonal control of glucose transport in FRTL-5 rat thyroid cells 44
High periostin expression correlates with aggressiveness in papillary thyroid carcinomas 44
Targeting the thyroid gland with thyroid-stimulating hormone (TSH)-nanoliposomes. 44
Carcinoma midollare della tiroide: identificazione di una nuova mutazione 44
Oleacein inhibits STAT3, activates the apoptotic machinery, and exerts anti-metastatic effects in the SH-SY5Y human neuroblastoma cells 44
Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches. 43
MicroRNAs as Biomarkers in Thyroid Carcinoma 43
An activating mutation in the thyrotropin receptor causing thyrotoxicosis in a Hurtle cell thyroid carcinoma 43
Detection of an activating mutation of the TSH receptor in a case of an autonomously hyperfunctioning thyroid insular carcinoma 43
Quercetin improves the effects of sorafenib on growth and migration of thyroid cancer cells. 43
Gemcitabine-loaded PEGylated unilamellar liposomes vs GEMZAR®: Biodistribution, pharmacokinetic features and in vivo antitumor activity 43
Control of PTEN gene expression in normal and neoplastic thyroid cells 42
Prohibitin is overexpressed in papillary thyroid carcinomas bearing the BRAFV600E mutation 42
Genetic analysis in fine needle aspiration biopsy of the thyroid: a new tool for the clinic. 42
Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells 42
Dihydrotanshinone exerts antitumor effects and improves the effects of cisplatin in anaplastic thyroid cancer cells 42
Phytochemicals in thyroid cancer: analysis of the preclinical studies 42
Valutazione Antitumorale in Vitro di Liposomi Contenenti Gemcitabina ed un Nuovo Inibitore Tirosin-Chinasico di Sintesi 41
BRAF V600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas 41
Molecular profiles of cancer stem-like cell populations in aggressive thyroid cancers. 41
Analysis of YAP1 expression in papillary thyroid cancer, lymph node metastases and medullary thyroid cancer. 41
Safety Evaluation of Subchronic Oral Administration of Oleuropein and its Semisynthetic Peracetylated Derivative 41
Identification of thyroid-associated serum microrna profiles and their potential use in thyroid cancer follow-up 40
A synonymous RET substitution enhances the oncogenic effect of an in-cis missense mutation by increasing constitutive splicing efficiency. 40
Correlazione genotipo/fenotipo negli adenomi autonomi iperfunzionanti della tiroide con e senza mutazioni nella proteina Gs alfa o nel recettore del TSH 40
A Phe 486 thyrotropin receptor mutation in an autonomously functioning follicular carcinoma that was causing hyperthyroidism 40
Expression of YAP1 in aggressive thyroid cancer 40
Multidrug Carriers Encapsulating Gemcitabine and Paclitaxel for the Treatment of Multi-Drug Resistant Tumors 39
Clinical implication of BRAF mutation in thyroid carcinoma 39
Expression of PAX8 target genes in Papillary Thyroid Carcinoma. 39
Totale 5.303
Categoria #
all - tutte 148.699
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 148.699


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021156 0 0 0 0 28 15 12 14 36 7 11 33
2021/2022873 4 3 7 185 117 11 37 210 80 59 147 13
2022/20232.398 738 98 73 186 246 204 5 174 351 135 146 42
2023/2024834 164 142 57 43 49 229 13 36 16 17 12 56
2024/20253.321 551 316 155 180 123 415 24 87 450 286 227 507
2025/20264.358 243 925 961 1.549 680 0 0 0 0 0 0 0
Totale 12.322